For the rash, your doctor may prescribe: creams and ointments to soothe your skin oral drugs to reduce skin cell production light therapy to reduce inflammation The goal of rash treatment is to ...

Parents have expressed their devastation over the discontinuation of a cream renowned for its nappy rash healing properties ... distinctive Metanium yellow brand colour alongside the purple ...

You can contact her via email: [email protected] A woman suffering from continual breakouts decided to take unconventional measures and covered her face in diaper rash cream. Zaia (_nvrseeme ...

An internal investigation by the broadcaster examined eight complaints involving Brand when he was a radio presenter. By Reggie Ugwu An investigation by the BBC of allegations against the comedian ...

The fashion search platform Lyst has dropped its latest ranking of fashion's hottest brands. Lyst compiled the list by analyzing its 200 million shoppers' behavior in the fourth quarter of 2024 ...

Cipla Q3 results review: The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after the company delivered a solid quarterly earnings ...

Cipla has been helping extend the reach of affordable life-saving HIV/AIDS medications since 2001. The company supplies antiretroviral (ARV) medicines to 64 countries by mostly participating in the ...

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business.

Cipla Ltd. has expressed optimism about exceeding its FY25 guidance, supported by strong operational performance and a focused strategy. The company stated that supply challenges related to Lanreotide ...

HYDERABAD/BENGALURU (Reuters) -Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by strong domestic demand, and said the U.S ...

Drug major Cipla reported a 49% year-on-year jump in its December quarter consolidated net profit, reaching Rs 1,571 crore, compared to Rs 1,056 crore in the same period last year. The profit after ...

In Q3FY25, we delivered growth across all our various geographies, despite of a supply challenge in the US," said Umang Vohra, managing director and global chief executive officer of Cipla. "Going ...